Calithera Biosciences, Inc. (CALA)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Jul 31, 2025, 8:00 PM EDT
Calithera Biosciences Market Cap
Calithera Biosciences has a market cap or net worth of $487.00 as of August 1, 2025. Its market cap has decreased by -99.80% in one year.
Market Cap
487.00
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since October 3, 2014, Calithera Biosciences's market cap has decreased from 167.19M to 487.00, a decrease of -100.00%. That is a compound annual growth rate of -69.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 25, 2025 | 487.00 | - |
| Dec 31, 2024 | 487.00 | -99.67% |
| Dec 29, 2023 | 146.18K | -99.08% |
| Dec 30, 2022 | 15.86M | -68.18% |
| Dec 31, 2021 | 49.84M | -85.61% |
| Dec 31, 2020 | 346.44M | 12.83% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo, Inc. | 1.80B |
| Veradigm | 832.17M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 546.09M |
| Glass House Brands | 396.28M |
| CytoDyn | 371.08M |
| Nika Pharmaceuticals | 366.89M |
| Northwest Biotherapeutics | 361.28M |